Injured leg, hepatitis-B 11271...India
On 19 Nov 2016, a 46-year-old male visited the practitioner for treatment of his injury-related leg pain, numbness and burning sensation. He had met with an accident in Jan 2015 when he suffered head and multiple leg injuries. He was treated in a hospital where the doctors implanted a surgical steel rod in his leg. Now the doctor told him that the cause of his pain was the steel rod and advised him to go to a hospital for its removal. However, in the pre-surgery screening test on 9 November, the patient was found to be infected with hepatitis-B virus (HBV), so the doctors postponed the surgery. Instead, they prescribed Tenvir-300 for HBV, to be taken lifelong. As this disease is highly contagious, the same tablets were given to his wife too, alongside the vibro remedy given to both of them. Since the rod was causing severe pain in the leg, the practitioner put him on the following:
For leg pain, numbness and burning:
#1. CC3.7 Circulation + CC10.1 Emergencies + CC18.5 Neuralgia + CC20.3 Arthritis + CC20.4 Muscles & Supportive tissue + CC20.5 Spine…6TD in water
For hepatitis-B:
# 2. CC4.2 Liver & Gallbladder tonic + CC4.11 Liver & Spleen + CC10.1 Emergencies + CC12.1 Adult tonic + CC15.1 Mental & Emotional tonic…QDS in water
The patient did not take any allopathic medicines for his leg pain. On 24 Dec 2016, the patient felt only 20% improvement in all his symptoms.
So #1 was replaced by:
#3. CC20.7 Fractures + #1…6TD in water
In Feb 2017, after taking #3 for two months, the leg pain, numbness and burning sensation were completely gone; so the dosage was reduced to QDS. Since the surgical rod is still there in his leg, the patient feels happier to continue #3 at QDS. As of June 2018 there has been no recurrence of any symptoms and the patient comes for refills every two months.
As for HBV, the main indicator is quantitative real time PCR value which was very high, over 10 million in the beginning on 9 Nov 2016. By 4 Mar 2017, it had come down to 5467 and finally to TND (target not detected) on 19 Oct 2017. As the patient was receiving combo #2 alongside allopathic medicine, one can’t assess the contribution made by vibrionics to this successful outcome of hepatitis-B treatment.